At-home Genetic Testing Market Expected to Reach $20.2 Billion by 2035

According to a new report published by Allied Market Research, titled, “At-home Genetic Testing Market," The at-home genetic testing market was valued at $2.2 billion in 2023, and is estimated to reach $20.2 billion by 2035, growing at a CAGR of 20.3% from 2024 to 2035.

At-home genetic testing refers to a type of genetic analysis that individuals can perform in the comfort of their own homes using a test kit provided by a company. These tests typically involve collecting a saliva or cheek swab sample and sending it to a laboratory for DNA analysis. The results provide insights into various genetic traits, ancestry, health predispositions, carrier status for hereditary conditions, and sometimes even lifestyle factors like metabolism and nutrition. At-home genetic testing has gained popularity due to its convenience, accessibility, and the growing interest in personalized health and wellness.

According to at-home genetic testing market analysis the major factors which drive the global at-home genetic testing market include the growing interest in ancestry and genealogy has fueled demand, as individuals seek insights into their ethnic backgrounds and familial connections. In addition, the rise in prevalence of genetic disorders and chronic diseases led to increased interest in predictive testing, enabling early detection and proactive health management thereby driving the growth of at-home genetic testing market size. The expansion of telehealth services and digital health platforms has further facilitated market growth by providing consumers with easy access to genetic counseling and online result interpretation.

Furthermore, according to at-home genetic testing market trends analysis rises in advancements, particularly genetic testing, has significantly reduced the cost of genetic testing, making at-home kits more affordable and accessible. The integration of artificial intelligence (AI) and big data analytics in genetic testing has also improved the accuracy and reliability of results, enhancing consumer trust in these services. The growing trend of preventive healthcare has encouraged individuals to take proactive steps in understanding their genetic risks, further drives the growth of at-home genetic testing market size.

However, the high cost of ablation devices and procedures, which can limit access, especially in low-income regions and risk of complications, such as damage to surrounding tissues, and the potential for tumor recurrence are the factors which may restrict the at-home genetic testing market growth. In contrast, according to at-home genetic testing market opportunity analysis expanding healthcare infrastructure in emerging markets, increasing awareness about cancer treatments, and rising technological advancements provides an opportunity for market growth.

The at-home genetic testing industry is classified on the basis of type, application, and region. Depending on the type, the market is classified into carrier test, nutrigenomics test, predictive and presymptomatic test, ancestry, and others. The ancestry segment dominated the at-home genetic testing market share in 2023, primarily due to the rising consumer interest in genealogy and personal heritage exploration. The increasing availability and affordability of direct-to-consumer (DTC) genetic testing kits from companies such as AncestryDNA, 23andMe, and MyHeritage significantly contributed to at-home genetic testing market Growth.

Advances in DNA sequencing technologies and bioinformatics have enhanced the accuracy and depth of ancestry reports, attracting a larger consumer base. Additionally, the growing integration of genetic databases with historical and migration records has made ancestry testing more insightful and engaging.

However, according to at-home genetic testing market forecast analysis the carrier test segment is expected to register the highest CAGR during the forecast period. This growth is attributed to increasing awareness of genetic disorders, rising demand for family planning and reproductive health testing, and advancements in next-generation sequencing (NGS) technology. Carrier testing helps individuals determine their risk of passing inherited genetic conditions, such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease, to their offspring.

Depending on the application, the market is segmented into cancer diagnosis, genetic disease diagnosis, ancestry, and others. The ancestry segment dominated the at-home genetic testing market share in 2023. This was attributed to the growing integration of genetic databases with historical and migration records, which has made ancestry testing more insightful and engaging. The segment’s dominance was further supported by aggressive marketing strategies, strong consumer engagement through social media, and the rising trend of individuals seeking connections with distant relatives.

While concerns over data privacy and genetic information security exist, companies have implemented measures to ensure data protection, maintaining consumer trust and market expansion. However, the genetic disease diagnosis segment is expected to register the highest CAGR during the forecast period. This growth is attributed to the rising prevalence of genetic disorders, increasing awareness of early disease detection, and advancements in genetic testing.

Region wise, North America was the largest shareholder in the global at-home genetic testing industry in 2023, owing to high consumer awareness, the strong presence of key market players, and favorable regulatory frameworks. The growing demand for personalized medicine, along with advancements in genetic testing technologies, further supported market expansion in the region. In addition, increased adoption of direct-to-consumer (DTC) genetic tests and strong healthcare infrastructure contributed to North America's dominance.

However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period owing to increasing healthcare expenditure, and growing adoption of direct-to-consumer (DTC) genetic testing. In addition, rise in technological advancements, expanding market presence of key players, and supportive government initiatives further drive the region’s rapid growth. Further, a rising focus on personalized medicine and ancestry testing contributes to market expansion.

Key Findings of The Study

• By type, the ancestry segment was the highest contributor to the market in 2023. However, carrier test segment is expected to register highest CAGR in forecast period.
• By application, the ancestry segment was the highest contributor to the market in 2023. However, genetic disease diagnosis segment is expected to register highest CAGR in forecast period.
• By region, North America garnered the largest revenue share in 2023. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period.